Similar articles

• In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura.

  McMillan R, Longmire RL, Tavassoli M, Armstrong S, Yelenosky R. McMillan R, et al. N Engl J Med. 1974 Jan 31;290(5):249-51. doi: 10.1056/NEJM197401312900505. N Engl J Med. 1974. PMID: 4855568 No abstract available.
• Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response.

  Dixon R, Rosse W, Ebbert L. Dixon R, et al. N Engl J Med. 1975 Jan 30;292(5):230-6. doi: 10.1056/NEJM197501302920503. N Engl J Med. 1975. PMID: 1078594
• Pathophysiological significance of platelet-associated IgG in idiopathic thrombocytopenic purpura.

  Uike N. Uike N. Nihon Ketsueki Gakkai Zasshi. 1985 Sep;48(6):1459-72. Nihon Ketsueki Gakkai Zasshi. 1985. PMID: 4090928 No abstract available.
• Autoimmune platelet destruction: idiopathic thrombocytopenic purpura.

  Kelton JG, Gibbons S. Kelton JG, et al. Semin Thromb Hemost. 1982 Apr;8(2):83-104. doi: 10.1055/s-2007-1005045. Semin Thromb Hemost. 1982. PMID: 6210960 Review. No abstract available.
• Current concepts of the pathogenesis and management of idiopathic thrombocytopenic purpura.

  Clancy RL, Trent RJ. Clancy RL, et al. Aust N Z J Med. 1977 Jun;7(3):312-9. doi: 10.1111/j.1445-5994.1977.tb03696.x. Aust N Z J Med. 1977. PMID: 334139 Review. No abstract available.